You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endocrine Treatment

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

A Retrospective Study for Multiple Endocrine Neoplasia

Recruiting
  • Multiple Endocrine Neoplasia
  • no intervention
  • Taipei, Taiwan
    National Taiwan University Hospital
Apr 2, 2023

Breast Cancer Trial (Standard of care administration of Endocrine therapy, Dose-frequency escalation administration of Endocrine

Not yet recruiting
  • Breast Cancer
  • Standard of care administration of Endocrine therapy
  • Dose-frequency escalation administration of Endocrine therapy
  • (no location specified)
Feb 22, 2023

CDK4/6 Inhibitors Combined With Endocrine Therapy and Subsequent

Not yet recruiting
  • Breast Cancer
  • +3 more
  • Different treatment regimens following progression on CDK4/6 inhibitors.
  • (no location specified)
Sep 5, 2023

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Endocrine Neoplasms

Recruiting
  • Endocrine Tumors
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 26, 2023

    Role of Endocrine Disruptors in Thyroid Cancer

    Recruiting
    • Endocrine Disruptor Chemicals
    • Thyroid Cancer
    • Blood and urine diagnostic evaluation
    • Milan, Italy
      Istituto Auxologico Italiano, IRCCS
    Feb 28, 2023

    Women With Endocrine and Reproductive-Related Conditions

    Recruiting
    • Endocrine Disease
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Breast Cancer, Advanced Breast Cancer Trial in Shanghai (Everolimus 10 mg, CDK4/6 Inhibitor SHR6390, Aromatase inhibitor and

      Not yet recruiting
      • Breast Cancer
      • Advanced Breast Cancer
      • Everolimus 10 mg
      • +2 more
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Jul 14, 2023

      Breast Cancer. Real Clinical Practice in Russia

      Recruiting
      • Breast Cancer
      • Neoadjuvant Endocrine Therapy
      • Tamoxifen 20mg
      • +4 more
      • Moscow, Russian Federation
        Blokhin's Russian Cancer Research Center
      Apr 5, 2023

      Breast Cancer, Hot Flash Due to Medication Trial (Oxybutynin, Venlafaxine)

      Not yet recruiting
      • Breast Cancer
      • Hot Flash Due to Medication
      • (no location specified)
      Oct 24, 2023

      Maternal Endocrine System and Metabolic Diseases and Offspring

      Not yet recruiting
      • Thyroid Dysfunction
      • Diabetes Mellitus
        • (no location specified)
        Jul 17, 2023

        Children With Endocrine and Metabolic-Related Conditions

        Recruiting
        • Adrenal Insufficiency
        • +4 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Dec 22, 2022

          Breast Cancer Trial in Beijing, Guangzhou (TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen, Placebo capsules, Letrozole,

          Not yet recruiting
          • Breast Cancer
          • TQB3616 capsules, Letrozole, Anastrozole, Tamoxifen
          • Placebo capsules, Letrozole, Anastrozole, Tamoxifen
          • Beijing, Beijing, China
          • +1 more
          Mar 10, 2023

          Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma Trial in Shanghai (individualized mRNA

          Not yet recruiting
          • Adrenal Cortical Carcinoma
          • +3 more
          • individualized mRNA neoantigen vaccine (mRNA-0523-L001)
          • Shanghai, Shanghai, China
            Ruijin hospital, Shanghai Jiao-Tong University School of Medicin
          Nov 19, 2023

          Locally Advanced or Metastatic Breast Cancer Trial in Guangzhou (SPH4336 Tablets, SPH4336 Tablets Placebo)

          Not yet recruiting
          • Locally Advanced or Metastatic Breast Cancer
          • SPH4336 Tablets
          • SPH4336 Tablets Placebo
          • Guangzhou, Guangdong, China
            Affiliated Cancer Hospital, Sun Yat-sen University
          May 8, 2023

          Bruxism Trial

          Not yet recruiting
          • Bruxism
            • (no location specified)
            Oct 14, 2023

            Immune Checkpoint Inhibitors(ICPis)-Induced Endocrine

            Completed
            • Immune Checkpoint Inhibitor
            • Endocrine Toxicity
              • Nanjing, Jiangsu, China
                First Affiliated Hospital, Nanjing Medical University
              Jan 6, 2023

              Metastatic Cancer, Breast Cancer, Lobular Breast Carcinoma Trial in Madison (18F-fluorofuranylnorprogesterone, Liquid Biopsy,

              Recruiting
              • Metastatic Cancer
              • +2 more
              • Madison, Wisconsin
                UW Carbone Cancer Center
              Oct 10, 2023

              Quality of Life and Tolerance of Patients Treated With

              Not yet recruiting
              • Metastatic Neuroendocrine Tumour
                • Lyon, France
                  Hospices Civils de Lyon, Hopital Lyon Sud
                Sep 12, 2023

                Breast Cancer Trial in Wuhan (Adebrelimab, dalpiciclib)

                Recruiting
                • Breast Cancer
                • Wuhan, Hubei, China
                  Tongji Hospital Affiliated of Tongji Medical College Huazhong Un
                Nov 20, 2023

                Endocrine-metabolic-immunological Axis During Female Menstrual

                Recruiting
                • Menstrual Cycle
                  • Bonn, Germany
                    Rheinische Friedrich-Wilhelms-Universität Bonn
                  Oct 4, 2023

                  Studies of Inherited Diseases of Metabolism

                  Completed
                  • Multiple Endocrine Neoplasia
                    • Bethesda, Maryland
                      National Institutes of Health Clinical Center
                    Jan 19, 2023

                    Breast Cancer Trial in Zhengzhou (Capecitabine+endocrine therapy, Placebo+endocrine therapy)

                    Recruiting
                    • Breast Cancer
                    • Capecitabine+endocrine therapy
                    • Placebo+endocrine therapy
                    • Zhengzhou, Henan, China
                      Henan cancer hospital
                    Nov 19, 2022

                    Adults With Endocrine and Metabolic-Related Conditions

                    Recruiting
                    • Endocrine Diseases
                      • Bethesda, Maryland
                        National Institutes of Health Clinical Center
                      Aug 18, 2022

                      Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy

                      Recruiting
                      • Advanced Breast Cancer
                      • The combination of Dalpiciclib with physician-selected endocrine therapy
                      • Chemotherapy selected by the physician
                      • Beijing, Beijing, China
                        Peking Union Medical College Hospital
                      May 22, 2023